Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities

por Veraart, Jolien K E, Kamphuis, Jeanine, Schlegel, Mathis, Schoevers, Robert A
Publicado 2021

Characteristics of patients expressing an interest in ketamine treatment: results of an online survey

por Veraart, Jolien K. E., Smith-Apeldoorn, Sanne Y., Trueman, Hayley, de Boer, Marrit K., Schoevers, Robert A., McShane, Rupert
Publicado 2018

Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review

por Veraart, Jolien K E, Smith-Apeldoorn, Sanne Y, Bakker, Iris M, Visser, Berber A E, Kamphuis, Jeanine, Schoevers, Robert A, Touw, Daan J
Publicado 2021

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study

por Smith-Apeldoorn, Sanne Y., Veraart, Jolien K. E., Ruhé, Henricus G., aan het Rot, Marije, Kamphuis, Jeanine, de Boer, Marrit K., Schoevers, Robert A.
Publicado 2021

Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

por Smith-Apeldoorn, Sanne Y., Veraart, Jolien K. E., Kamphuis, Jeanine, van Asselt, Antoinette D. I., Touw, Daan J., aan het Rot, Marije, Schoevers, Robert A.
Publicado 2019

Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

por Smith-Apeldoorn, Sanne Y., Veraart, Jolien K. E., Kamphuis, Jeanine, van Asselt, Antoinette D. I., Touw, Daan J., aan het Rot, Marije, Schoevers, Robert A.
Publicado 2020